Vaccine using community-acquired respiratory distress syndrome toxin as an antigen against Mycoplasma pneumoniae in mice

Biochem Biophys Res Commun. 2022 Feb 26:594:81-87. doi: 10.1016/j.bbrc.2022.01.058. Epub 2022 Jan 19.

Abstract

Mycoplasma pneumoniae (Mp) is one of the most common causes of bacterial community-acquired pneumonia in humans. Because of the frequent epidemics and the emergence of antibiotic-resistant Mp, vaccines for Mp are urgently needed to ameliorate the pneumonia and secondary complications. The community-acquired respiratory distress syndrome (CARDS) toxin produced by Mp is a pathogenic factor that induces severe inflammatory responses in lung. Although blocking CARDS toxin is expected to mitigate the severity of Mp pneumonia, the potential of CARDS toxin as a vaccine antigen has not been assessed. Here, we examined the effectiveness of vaccine using recombinant CARDS toxin (rCARDS toxin) as an antigen in mice. Immunization with rCARDS toxin induced both rCARDS toxin- and Mp-specific antibody responses, indicating that CARDS toxin is located on the surface of Mp. In addition, immunization with rCARDS toxin decreased not only lung injury, neutrophil infiltration, and the production of inflammatory cytokines but also the persistence of Mp in lung after Mp challenge. Furthermore, we elucidated that the CARDS toxin on the surface of Mp facilitates the adherence of Mp to epithelial cells. In conclusion, we have demonstrated the potential of rCARDS toxin as a vaccine antigen to ameliorate Mp pneumonia by suppressing the inflammatory responses induced by Mp and the persistence of Mp in lung. These data support the development of novel vaccines for Mp pneumonia.

Keywords: Antibody; Epithelial cell; Mycoplasma pneumoniae; Respiratory tract; Toxin; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Animals
  • Antigens, Bacterial
  • Bacterial Proteins*
  • Bacterial Toxins*
  • Bacterial Vaccines*
  • Bronchoalveolar Lavage Fluid
  • Community-Acquired Infections
  • Humans
  • Inflammation
  • Lung / pathology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mycoplasma pneumoniae*
  • Pneumonia, Mycoplasma / microbiology*
  • Pneumonia, Mycoplasma / prevention & control*
  • Recombinant Proteins
  • Respiratory Distress Syndrome / microbiology*
  • Respiratory Distress Syndrome / prevention & control*

Substances

  • Antigens, Bacterial
  • Bacterial Proteins
  • Bacterial Toxins
  • Bacterial Vaccines
  • CARDS toxin, Mycoplasma pneumoniae
  • Recombinant Proteins